Real-world treatment (tx) patterns and clinical outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) in Germany: Results of a retrospective observational study (CONVINCE)

被引：0
|
作者：
Machtens, Stefan [1 ]
Schlack, Katrin [2 ]
Kubin, Thomas [3 ]
Ruhnke, Markus [4 ]
Schulte, Clemens [5 ]
Eisen, Anna [6 ]
Osowski, Ulrike [7 ]
Guenther, Silke [8 ]
Kearney, Mairead [8 ]
Lipp, Rainer [6 ]
Schmitz, Stephan H. [9 ]
机构：
[1] GFO Hosp Rhein Berg, Marien Hosp, Dept Urol, Bergisch Gladbach, Germany
[2] Univ Hosp Muenster, Dept Urol, Munster, Germany
[3] Clin Sudostbayern AG, Dept Hematol Oncol & Palliat Care, Clin Traunstein, Traunstein, Germany
[4] Helios Clin Aue, Clin Hematol Oncol & Palliat Med, Aue, Germany
[5] Practice Hematol & Oncol, Dortmund, Germany
[6] GermanOncol GmbH, Hamburg, Germany
[7] Merck Healthcare Germany GmbH, Merck KGaA, Weiterstadt, Germany
[8] Healthcare Business Merck KGaA, Darmstadt, Germany
[9] Med Care Ctr Oncol & Hematol, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：551 / 551
页数：1
相关论文
共 50 条
  • [21] Insights into second-line (2L) systemic treatment (tx) receipt in patients (pts) with metastatic urothelial carcinoma (mUC): Results of a retrospective observational study in Germany
    Niegisch, G.
    Kearney, M.
    Krieger, J.
    Osowski, U.
    Deiters, B.
    Maywald, U.
    Wilke, T.
    Grimm, M-O. J.
    ANNALS OF ONCOLOGY, 2024, 35 : S1154 - S1154
  • [22] Split-dose cisplatin (C) plus gemcitabine (G) use and associated clinical outcomes in the first-line (1L) treatment (tx) of locally advanced or metastatic urothelial cancer (la/mUC): results of a retrospective observational study in Germany (CONVINCE)
    Schlack, Katrin
    Kubin, Thomas W.
    Ruhnke, Markus
    Schulte, Clemens
    Machtens, Stefan
    Eisen, Anna
    Osowski, Ulrike
    Guenther, Silke
    Kearney, Mairead
    Lipp, Rainer
    Schmitz, Stephan
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 83 - 83
  • [23] Clinical outcomes by sex with atezolizumab (atezo) monotherapy in patients (pts) with locally advanced/metastatic urothelial carcinoma (mUC)
    Hoffman-Censits, J.
    Rosenberg, J. E.
    van Der Heijden, M.
    Dreicer, R.
    Perez Gracia, J. L.
    Petrylak, D. P.
    Retz, M. M.
    Sabbatini, R.
    Naglieri, E.
    Caserta, C.
    Maruzzo, M.
    Iacovelli, R.
    Galli, L.
    McDermott, R.
    Morales Barrera, R.
    Bonfill, T.
    De Ducla, S.
    Ding, B.
    Linsenmeier, J.
    Sternberg, C. N.
    ANNALS OF ONCOLOGY, 2019, 30 : 372 - +
  • [24] Real-world treatment patterns and clinical outcomes among patients with metastatic urothelial carcinoma.
    Geynisman, Daniel M.
    Broughton, Edward
    Alhasani, Hasan
    Hao, Yi
    Zhang, Ying
    Stwalley, Brian
    Le, Trong Kim
    Huo, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US.
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie A.
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Rey, Gabriel Gomez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 605 - 605
  • [26] Correction to: Nationwide Study of Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Urothelial Carcinoma in Hungary
    Anikó Maráz
    Bence Nagy
    Tamara Macher
    József Jeskó
    Erika Tischler
    Csaba Csongvai
    Mairead Kearney
    Advances in Therapy, 2024, 41 (2) : 881 - 882
  • [27] Split-dose cisplatin plus gemcitabine use and associated clinical outcomes in the first-line (1L) treatment of locally advanced or metastatic urothelial cancer (la/mUC): Results of a retrospective observational study in Germany (CONVINCE)
    Schlack, K.
    Kubin, T.
    Ruhnke, M.
    Schulte, C.
    Machtens, S.
    Eisen, A.
    Osowski, U.
    Guenther, S.
    Kearney, M.
    Lipp, R.
    Schmitz, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1216 - S1216
  • [28] Retrospective database analysis of real-world treatment patterns and sequencing in locally advanced or metastatic urothelial carcinoma patients receiving sacituzumab govitecan
    Mamtani, R.
    Katz, J.
    An, R.
    Boateng, F.
    Ghazi, Y.
    Brockman, M.
    Sierecki, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S1148 - S1149
  • [29] Treatment patterns, indicators of receiving systemic treatment, and clinical outcomes in metastatic urothelial carcinoma: A retrospective analysis of real-world data in Germany.
    Niegisch, Guenter
    Grimm, Marc-Oliver
    Hardtstock, Fraence
    Krieger, Julia
    Starry, Alexandra
    Osowski, Ulrike
    Guenther, Silke
    Deiters, Barthold
    Maywald, Ulf
    Wilke, Thomas
    Kearney, Mairead
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [30] Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility
    Morgans, Alicia K.
    Galsky, Matthew D.
    Wright, Phoebe
    Hepp, Zsolt
    Chang, Nancy
    Willmon, Candice L.
    Sesterhenn, Steve
    Liu, Yutong
    Sonpavde, Guru P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (08) : 357e11 - 357e21
12345